First-pass extracted concept

physical stimuli-responsive CRISPR-Cas9 platforms

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

This review systematically explores recent advances in physical stimuli-responsive CRISPR-Cas9 platforms, detailing their design strategies, activation mechanisms, and proof-of-concept applications.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1comparative advantagesupports2026Source 1DOI PubMed

Externally applied physical stimuli offer superior spatiotemporal precision, reversibility, and biocompatibility for triggering CRISPR-Cas9 activity compared with chemical molecule-inducible systems.

Claim 2functional impactsupports2026Source 1DOI PubMed

Physical-stimuli-responsive CRISPR-Cas9 systems can enhance controllability, target specificity, and practical applicability across diverse biological settings.

Claim 3problem statementsupports2026Source 1DOI PubMed

Achieving spatiotemporally controlled gene editing within specific organs, tissues, or cells remains a major challenge because unregulated CRISPR-Cas9 activity can cause severe off-target effects that hinder clinical translation.

Claim 4translational gapsupports2026Source 1DOI PubMed

A persistent bench-to-bedside gap remains for physical stimuli-responsive CRISPR-Cas9 systems, motivating development toward clinically viable solutions.